T1D Exchange Principals Participate in Third International Conference on Progress of Regenerative Medicine and Its Cultural Impact

T1D Exchange Principals Participate in Third International Conference on Progress of Regenerative Medicine and Its Cultural Impact

Founder, Executive Director Dana Ball, Chief Medical Officer, Henry Anhalt DO, and Ten-Time Olympic Medalist Gary Hall, Jr., attending event in Vatican City from April 28–30, 2016

BOSTON, MA, April 27, 2016 – Dana Ball, T1D Exchange Co-Founder and Executive Director, Henry Anhalt, DO, Chief Medical Officer of T1D Exchange, and ten-time Olympic Medalist Gary Hall Jr. have been chosen among only 300 others to attend and speak at the 2016 Cellular Horizons Conference. The Stem for Life Foundation, STOQ and the Vatican’s Pontifical Council for Culture created this exclusive international event which gathers the world’s leading cell therapy scientists, physicians, patients, ethicists and leaders of faith, government, and philanthropy to discuss the latest cellular therapy breakthroughs and hope for the future. The 2016 event will have a unique focus on pediatric cancers and rare genetic diseases, as well as diseases that occur with aging.

Mr. Ball will be speaking on a special panel called, “Paying for Miracles,” moderated by Yahoo! News anchor, Katie Couric, examining how not-for-profits are approaching investment into cell therapy research and spending resources on the search for effective treatments. Additionally, Henry Anhalt, DO, Chief Medical Officer, T1D Exchange, will be giving an overview of type 1 diabetes, followed by a video tour of research centers developing cell therapy treatments for people with type 1 diabetes, led by Max Gomez. As part of the steering committee for this event, Dr. Anhalt will also be moderating the “Cell Therapy Research Discussion for Type 1 Diabetes” panel, which will examine unique approaches to treat and hopefully, one day, cure type 1 diabetes. Special Guest Gary Hall, Jr., Olympic Gold Medal Winner and T1D Exchange member and alliance manager, will be speaking about triumph while living with type 1 diabetes.

“We are excited to help elevate and explore this powerful concept that the cells of our bodies may be the foundation to understand cause and effect of disease, which may lead to new targets to prevent, treat and maybe  even cure diseases such as type 1 diabetes,” said Dana Ball, Co-Founder and Executive Director of T1D Exchange, “It is a great privilege to be included with outstanding like-minded individuals committed to reducing global suffering and inspiring hope for those who suffer from illnesses around the world.”

The event, held in Vatican City, will feature participants from a wide range of backgrounds and expertise. It seeks to explore the ways science, technology, information, and communication will enable personalized medical solutions, remove inefficiencies, increase access and affordability and improve clinical outcomes at an individual level.

The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact will rally the world around a powerful idea ─ that the cells of our bodies hold the potential to vanquish disease, including type1 diabetes.  Science is advancing such that, instead of treating symptoms associated with disease, scientists around the word are working on developing effective treatments targeting the underlying cause of the disease  in an effort to reduce global suffering and inspire hope for people around the world living with type I diabetes and other autoimmune diseases,” said Dr. Robin Smith, President of The Stem For Life Foundation.

Mr. Ball co-founded T1D Exchange, a non-profit organization that offers a dynamic, multi -purpose, real-world platform that provides researchers access to aggregated clinical, biological, patient-reported outcomes and electronic health record data, all while fostering collaboration among patients, physicians, researchers, and industry. The goal is to speed the research process and direct novel treatments and clinical care that will address unmet needs.

Who:     Dana Ball, Executive Director and Co-Founder – T1D Exchange

                Henry Anhalt, DO, Chief Medical Officer – T1D Exchange

                Gary Hall, Jr., Olympic Gold Medalist

What:   Cellular Horizons:  The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact

When: Thursday, April 28, 2016 – Saturday, April 30, 2016

Where: Vatican City

The conference aims to unite people of all races, religious beliefs, cultural and economic backgrounds in a global conversation about the healing potential of cell therapy and the importance of getting approved therapies to people suffering with debilitating medical conditions around the world.

 

About The Stem For Life Foundation (SFLF)

The Stem For Life Foundation (SFLF) is the educational and advocacy subsidiary of The Cura Foundation and is devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions, as opposed to merely treating their symptoms. The Foundation stands at the forefront of a fundamental shift away from traditional drug treatment in favor of amplifying the body’s natural repair mechanisms to vanquish disease. For more information on The Stem For Life Foundation, please visit http://www.stemforlife.org.  To follow the Vatican event on Twitter, please join the conversation @StemForLife or via the hashtag #UNITETOCURE

 

About T1D Exchange

T1D Exchange is a program of Unitio which brings together all the communities invested in working toward improved treatment and a better, faster path to a cure of type 1 diabetes. Researchers, healthcare professionals, industry, patients, families and supporters all contribute experience, knowledge and perspective through a variety of integrated platforms, including a Clinic Network, Clinic Registry, Biobank, Living Biobank and the online patient/caregiving community, Glu. T1D Exchange offers researchers easy access to aggregated clinical, biological, patient-reported outcomes and electronic health data while fostering collaboration among stakeholders. The result is direct treatments and clinical care that will serve unmet needs and speed the research process, and ultimately improve the daily lives of everyone affected by T1D.

 

Contact

T1D Exchange
Jim Baptiste, Matter Communications
Phone: +1-978-518-4527
Email: jbaptiste@matternow.com

 

Stem For Life
Linda Burns, Allison+Partners
Phone: +1-646-428-0606
Email: Linda@allisonpr.com

 

 

2017-02-17T13:39:25+00:00